Is a 6-week course of ganciclovir therapy effective for chorioretinitis in infants with congenital cytomegalovirus infection?

Abstract

Effective treatment for chorioretinitis caused by congenital cytomegalovirus (CMV) infection remains unknown. We report an infant with congenital CMV infection, who required a 6-month course of antiviral therapy to control his chorioretinitis. Long-term treatment may be necessary for managing congenital CMV-associated chorioretinitis.

• Authors: Kensuke Shoji, Naoki Ito, Yushi Ito, Naoki Inoue, Shingo Adachi, Takuya Fujimaru, Tomoo Nakamura, Sachiko Nishina, Noriyuki Azuma, Akihiko Saitoh
• Journal: The Journal of pediatrics (J Pediatr) Vol. 157 Issue 2 Pg. 331-3 (Aug 2010) ISSN: 1097-6833 [Electronic] United States
• PMID: 20400108 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright (c) 2010 Mosby, Inc. All rights reserved.

Chemical References

• Antiviral Agents
• Ganciclovir

Topics

• Adult
• Antiviral Agents (therapeutic use)
• Chorioretinitis (congenital, drug therapy)
• Cytomegalovirus Infections (congenital, drug therapy)
• Drug Administration Schedule
• Female
• Ganciclovir (therapeutic use)
• Humans
• Infant
• Male
• Pregnancy
• Pregnancy Complications, Infectious
• Time Factors
• Treatment Outcome